Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Nov 13;4(6):461-466.
doi: 10.1192/bjo.2018.64. eCollection 2018 Nov.

Neuropsychiatric profile and psychotropic medication use in adults with autism spectrum disorder: results from the Australian Longitudinal Study of Adults with Autism

Rachael C Cvejic  1 , Samuel R C Arnold  2 , Kitty-Rose Foley  3 , Julian N Trollor  4
Affiliations

Neuropsychiatric profile and psychotropic medication use in adults with autism spectrum disorder: results from the Australian Longitudinal Study of Adults with Autism

Rachael C Cvejic et al. BJPsych Open. .

Abstract

Background: Children and adolescents with autism spectrum disorder (ASD) are a highly medicated group. Few studies have examined the neuropsychiatric profile and patterns of psychotropic medication use among adults with ASD.

Aims: To describe and compare the neuropsychiatric profile and psychotropic medication use in a cohort of adults with ASD and non-autistic controls.

Method: Baseline data from a survey-based, longitudinal study of adults with ASD in Australia. Participants were 188 adults with ASD and 115 controls aged 25-80 years.

Results: ASD was associated with increased odds of psychotropic medication use even when controlling for the presence of any neurological or psychiatric disorder. There were no corresponding indications for 14.4% of psychotropic medications prescribed to adults with ASD.

Conclusions: This study found substantial psychotropic prescribing for adults with ASD. Patterns of psychotropic medication use may reflect prescribing for behavioural indications despite limited evidence to support this practice.

Declaration of interest: None.

Keywords: Autism spectrum disorder; prescribing; psychiatric disorder; psychotropic medication.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Summary of indication status by class of psychotropic medications prescribed to individuals with autism spectrum disorder.
See this image and copyright information in PMC

References

    1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-5) (5th edn). APA, 2013. - PubMed
    1. Croen LA, Zerbo O, Qian Y, Massolo M, Rich S, Sidney S, et al. The health status of adults on the autism spectrum. Autism 2015; 19: 814–23. - PubMed
    1. Nylander L, Axmon A, Björne P, Ahlström G, Gillberg C. Older adults with autism spectrum disorders in Sweden: a register study of diagnoses, psychiatric care utilization and psychotropic medication of 601 individuals. J Autism Dev Disord 2018; 48: 3076–85. - PMC - PubMed
    1. Nah Y-H, Brewer N, Young RL, Flower R. Brief report: screening adults with autism spectrum disorder for anxiety and depression. J Autism Dev Disord 2018; 48: 1841–6. - PubMed
    1. Aman MG, Lam KS, Van Bourgondien ME. Medication patterns in patients with autism: temporal, regional, and demographic influences. J Child Adolesc Psychopharmacol 2005; 15: 116–26. - PubMed